Overview on Human Breast Cancer with Focus on Prognostic and Predictive Factors with Special Attention on the Tumour Suppressor Gene P53
- 1 January 1996
- journal article
- review article
- Published by Taylor & Francis in Acta Oncologica
- Vol. 35 (sup5) , 96-102
- https://doi.org/10.3109/02841869609083980
Abstract
A long list of potential prognostic markers has been analysed for breast cancer, some of them will be reviewed in this article. The lymph node status is still the best prognostic marker. The lymph node status combined with information on tumour size, receptor- and proliferation status of the tumour should be analysed as standard for all breast cancer patients. Prognostic information for breast cancer patients has also been described for the membrane protein c-erbB2, the protease cathepsin D, plasminogen activators and inhibitors, certain oncogenes and tumour suppressor genes. Some of these factors also give potential additional information on the response to different oncological therapies, and are better denoted predictive factors. In this overview we shortly describe the above mentioned prognostic factors with major focus on the tumour suppressor gene p53 and its prognostic value and potential predictive value.Keywords
This publication has 40 references indexed in Scilit:
- c-erbB-2 expression and benefit from adjuvant chemotherapy and radiotherapy of breast cancerEuropean Journal Of Cancer, 1995
- S-phase fraction and survival benefit from adjuvant chemotherapy or radiotherapy of breast cancerBritish Journal of Cancer, 1994
- Structure and function of type II DNA topoisomerasesBiochemical Journal, 1994
- c-erbB-2 Expression and Response to Adjuvant Therapy in Women with Node-Positive Early Breast CancerNew England Journal of Medicine, 1994
- Cathepsin D, both a prognostic factor and a predictive factor for the effect of adjuvant tamoxifen in breast cancerEuropean Journal Of Cancer, 1994
- Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell LineScience, 1992
- Hyperthermic antiblastic perfusion for the treatment of soft tissue limb sarcomaAnnals of Oncology, 1992
- Function and Regulation of the Human Multidrug Resistance GenePublished by Elsevier ,1992
- QUANTITATIVE OESTRADIOL RECEPTOR VALUES IN PRIMARY BREAST CANCER AND RESPONSE OF METASTASES TO ENDOCRINE THERAPYThe Lancet, 1981
- Estrogen receptor status: an important variable in predicting response to endocrine therapy in metastatic breast cancerPublished by Elsevier ,1980